2-166039633-T-G

Variant summary

Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_001165963.4(SCN1A):​c.2416-37A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.707 in 1,561,032 control chromosomes in the GnomAD database, including 393,177 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.74 ( 41772 hom., cov: 31)
Exomes 𝑓: 0.70 ( 351405 hom. )

Consequence

SCN1A
NM_001165963.4 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.192
Variant links:
Genes affected
SCN1A (HGNC:10585): (sodium voltage-gated channel alpha subunit 1) Voltage-dependent sodium channels are heteromeric complexes that regulate sodium exchange between intracellular and extracellular spaces and are essential for the generation and propagation of action potentials in muscle cells and neurons. Each sodium channel is composed of a large pore-forming, glycosylated alpha subunit and two smaller beta subunits. This gene encodes a sodium channel alpha subunit, which has four homologous domains, each of which contains six transmembrane regions. Allelic variants of this gene are associated with generalized epilepsy with febrile seizures and epileptic encephalopathy. Alternative splicing results in multiple transcript variants. The RefSeq Project has decided to create four representative RefSeq records. Three of the transcript variants are supported by experimental evidence and the fourth contains alternate 5' untranslated exons, the exact combination of which have not been experimentally confirmed for the full-length transcript. [provided by RefSeq, Oct 2015]
SCN1A-AS1 (HGNC:54069): (SCN1A and SCN9A antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 2-166039633-T-G is Benign according to our data. Variant chr2-166039633-T-G is described in ClinVar as [Benign]. Clinvar id is 3255232.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.869 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCN1ANM_001165963.4 linkc.2416-37A>C intron_variant Intron 16 of 28 ENST00000674923.1 NP_001159435.1 P35498-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCN1AENST00000674923.1 linkc.2416-37A>C intron_variant Intron 16 of 28 NM_001165963.4 ENSP00000501589.1 P35498-1
SCN1AENST00000303395.9 linkc.2416-37A>C intron_variant Intron 15 of 27 5 ENSP00000303540.4 P35498-1
SCN1AENST00000375405.7 linkc.2383-37A>C intron_variant Intron 13 of 25 5 ENSP00000364554.3 P35498-2
SCN1AENST00000409050.1 linkc.2332-37A>C intron_variant Intron 13 of 25 5 ENSP00000386312.1 P35498-3

Frequencies

GnomAD3 genomes
AF:
0.738
AC:
112063
AN:
151948
Hom.:
41728
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.824
Gnomad AMI
AF:
0.645
Gnomad AMR
AF:
0.742
Gnomad ASJ
AF:
0.602
Gnomad EAS
AF:
0.891
Gnomad SAS
AF:
0.709
Gnomad FIN
AF:
0.756
Gnomad MID
AF:
0.522
Gnomad NFE
AF:
0.683
Gnomad OTH
AF:
0.680
GnomAD3 exomes
AF:
0.727
AC:
178504
AN:
245524
Hom.:
65691
AF XY:
0.717
AC XY:
95484
AN XY:
133248
show subpopulations
Gnomad AFR exome
AF:
0.830
Gnomad AMR exome
AF:
0.810
Gnomad ASJ exome
AF:
0.599
Gnomad EAS exome
AF:
0.897
Gnomad SAS exome
AF:
0.687
Gnomad FIN exome
AF:
0.746
Gnomad NFE exome
AF:
0.680
Gnomad OTH exome
AF:
0.677
GnomAD4 exome
AF:
0.704
AC:
992158
AN:
1408968
Hom.:
351405
Cov.:
23
AF XY:
0.701
AC XY:
493261
AN XY:
704152
show subpopulations
Gnomad4 AFR exome
AF:
0.828
Gnomad4 AMR exome
AF:
0.803
Gnomad4 ASJ exome
AF:
0.602
Gnomad4 EAS exome
AF:
0.895
Gnomad4 SAS exome
AF:
0.684
Gnomad4 FIN exome
AF:
0.749
Gnomad4 NFE exome
AF:
0.693
Gnomad4 OTH exome
AF:
0.697
GnomAD4 genome
AF:
0.738
AC:
112167
AN:
152064
Hom.:
41772
Cov.:
31
AF XY:
0.741
AC XY:
55090
AN XY:
74350
show subpopulations
Gnomad4 AFR
AF:
0.823
Gnomad4 AMR
AF:
0.742
Gnomad4 ASJ
AF:
0.602
Gnomad4 EAS
AF:
0.891
Gnomad4 SAS
AF:
0.709
Gnomad4 FIN
AF:
0.756
Gnomad4 NFE
AF:
0.682
Gnomad4 OTH
AF:
0.682
Alfa
AF:
0.694
Hom.:
7625
Bravo
AF:
0.741
Asia WGS
AF:
0.790
AC:
2746
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Jul 15, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 87% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 81. Only high quality variants are reported. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
12
DANN
Benign
0.69

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2126152; hg19: chr2-166896143; COSMIC: COSV57663252; COSMIC: COSV57663252; API